Wednesday, December 12, 2012

One more byte at the Apple (over patent rights)

Those who are regular readers of this blog are likely aware of the ongoing battle among computer/software and mobile device giants like Apple, Inc., Samsung, Inc., Google and HTC over intellectual property rights.  As many know, in August of this year, Apple, Inc. was awarded a 1.2 billion dollar jury verdict for patent infringement by Samsung. (See NY Times article).  The jury found that Samsung infringed several of Apple's design patents and one of its utility patents.  During the trial, Apple presented evidence that it spent millions of dollars and years of research to find a design for its iPhone which was ascetically pleasing and comfortable to use and hold. 

In the wake of the $1.2 billion decision, many have questioned whether design patents (covering the appearance of a product) and utility patents (covering the functionality of a product) are hurting consumers and innovation rather than helping.

As previously noted in my post "Patenting...Real. Comfortable. Genes?", the reason we have a patent system is routing in the U.S. Constitution.

The Framers of the United States Constitution knew of the importance of technological progress.
The Congress shall have the power...
To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries. (U.S. Constitution, Article I, § 8, clause 8).
This provides inventors with an incentive to create new products and processes. It also gives companies and investors (e.g. venture capitalists and stockholders), incentive to invest capital looking for a return on their capital investment.

Congress has limited the duration of the monopolistic protection. In return for the protection, the inventor must disclose his or her invention to the Patent Office which, in turn, discloses the information to the general public.

The Patent Act was drafted to accomplishes two goals. First, it encourages innovation and discovery through its incentive of limited monopoly Second, the patent system promotes the disclosure of useful technology to the general public by putting it in the public domain.

Opponents of design patents argue that the purported designs are too simple and therefore should be left in the public domain.  For example, with regard to Apple's design patents covering the curve design for its iDevices, opponents argue that these are simple design choices which lack any (or sufficient) creativity and are certainly not worthy of exclusivity which a patent provides.  Opponents of utility patents for mobile devices and software running on such devices make similar arguments saying that the software being patented lacks sufficient inventiveness to be worthy of patent protection.  Further, some opponents believe that patenting software and mobile devices stifle innovation of other software engineers and device manufacturers who fear lawsuits for patent infringement from the patent owner if they produce their own software or device.

Proponents of design and utility patents for software and mobile devices assert that the software and device companies need patent protection for their products.  These companies would argue, as Apple did, that they spend millions of dollars to research, develop, test, refine, re-design, and market their new products.  Absent patent protection, anyone could use the million dollar discoveries without having to invest a single dime. Further proponents of design and utility patents for software and mobile devices say that no one would invest in companies if anyone could use their discoveries for free.  As a result, high tech companies would cease to develop new and innovative software and devices.   Therefore, without the financial incentive of patent protection, new and innovated software and mobile devices will never be made.  Accordingly, proponents argue that software and mobile device patents accomplish the two goals of the Patent act, offering both economic development and providing a pathway for new software and products.

Sunday, December 2, 2012

Patenting... Real. Comfortable. Genes?

The U.S. Supreme Court has agreed to hear the appeal in ASSOC. FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC. to decide whether isolated human genes are patentable under the U.S. Patent Act (35 U.S.C. § 1 et seq.)  Many have strong opinions either for or against gene patents.  In order to have an intelligent, informed debate, it is important to consider why we have a patent system at all.  

The Framers of the United States Constitution knew of the importance of technological progress.
The Congress shall have the power...
To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries. (U.S. Constitution, Article I, § 8, clause 8).
This provides inventors with an incentive to create new products and processes.  It also gives companies and investors (e.g. venture capitalists and stockholders), incentive to invest capital looking for a return on their capital investment.

Congress has limited the duration of the monopolistic protection.  In return for the protection, the inventor must disclose his or her invention to the Patent Office which, in turn, discloses the information to the general public.

The Patent Act was drafted to accomplishes two goals.   First, it encourages innovation and discovery through its incentive of limited monopoly  Second, the patent system promotes the disclosure of useful technology to the general public by putting it in the public domain.

Opponents of gene patents say, "Keep your hands off my genes."  They argue that human genes are naturally occurring, not the creation of human hands, and thus, not the subject of patents.  Therefore, opponents say that genes are in the public domain for all to use.  Further, some opponents believe that patenting genes stifle innovation of other researchers who fear lawsuits for patent infringement from the patent owner if they conduct their own research pertaining to the patented gene.  In addition, some proponents believe that for public policy reasons and pubic health concerns, physicians should not be prevented from access to the best diagnostics and therapeutic treatments which may include the gene discoveries of another.

Proponents of gene patents assert that biotech and pharmaceutical companies need patent protection for isolated genes.  These companies spend millions (or even billions) of dollars to isolate genes and to discover the role that these genes play in disease or in the therapeutic treatment of disease.  Absent patent protection, anyone could use the million/billion dollar discovery without having to invest a single dime.  Further proponents of patenting genes say that no one would invest in companies if anyone could use their discoveries for free.  As a result, biotech companies would cease to develop new diagnostics and therapeutic treatments predicated on isolated gene sequences.  Therefore, without the financial incentive of patent protection, new genetic diagnostics and therapeutic treatments will never be made.  Without patent protection for gene discoveries, entire industries will be lost and/or negatively impacted.  Accordingly, proponents argue that patenting genes accomplishes the two goals of the Patent act, offering both economic development and providing a pathway for new discoveries of disease diagnostics and therapeutic treatments. 

 
© Stephen J. Weyer, Stites & Harbison, PLLC, 2012
Send email feedback- sweyer@stites.com